Novabay Pharmaceuticals Inc

ASE:NBY   3:38:48 PM EDT
0.47
-0.05 (-9.46%)
Earnings Announcements

Novabay Pharmaceuticals Reports Third Quarter 2021 Financial Results

Published: 11/11/2021 21:41 GMT
Novabay Pharmaceuticals Inc (NBY) - Novabay Pharmaceuticals Reports Third Quarter 2021 Financial Results.
Q3 Loss per Share $0.05.
Revenue is expected to be $3.35 Million
Adjusted EPS is expected to be -$0.05

Next Quarter Revenue Guidance is expected to be $4.03 Million
Next Quarter EPS Guidance is expected to be -$0.03

More details on our Analysts Page.